LOS ANGELES (AP) _ CytRx Corp. (CYTR) on Friday reported a loss of $3.3 million in its third quarter.
On a per-share basis, the Los Angeles-based company said it had a loss of 10 cents.
The cancer drug developer posted revenue of $250,000 in the period.
The company's shares closed at 75 cents. A year ago, they were trading at $2.10.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTR at https://www.zacks.com/ap/CYTR